Kathleen I. Seyb, Ph.D.

Affiliations: 
2005 University of Kansas, Lawrence, KS, United States 
Area:
Pharmacology
Google:
"Kathleen Seyb"
Mean distance: 30533.1
 

Parents

Sign in to add mentor
Mary L. Michaelis grad student 2005 University of Kansas
 (Prevention of beta-amyloid neurotoxicity by microtubule-stabilizing drugs: The calcium(2+) connection.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kong Q, Chang LC, Takahashi K, et al. (2014) Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. The Journal of Clinical Investigation. 124: 1255-67
Tang X, Seyb KI, Huang M, et al. (2012) A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction. Journal of Biomolecular Screening. 17: 314-26
Colton CK, Kong Q, Lai L, et al. (2010) Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity. Journal of Biomolecular Screening. 15: 653-62
Seyb KI, Schuman ER, Ni J, et al. (2008) Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform. Journal of Biomolecular Screening. 13: 870-8
Seyb KI, Ansar S, Li G, et al. (2007) p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide. Journal of Molecular Neuroscience : Mn. 31: 23-35
Seyb KI, Ansar S, Bean J, et al. (2006) beta-Amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton. Journal of Molecular Neuroscience : Mn. 28: 111-23
Michaelis ML, Seyb KI, Ansar S. (2005) Cytoskeletal integrity as a drug target. Current Alzheimer Research. 2: 227-9
Michaelis ML, Ansar S, Chen Y, et al. (2005) {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. The Journal of Pharmacology and Experimental Therapeutics. 312: 659-68
See more...